Study Title
11SI Pediatric Constipation
Purpose
To evaluate the long term safety and efficacy of Lubiprostone 12 or 24 mcg twice daily.
Eligibility
Contact Principal Investigator for Information
Study Process
Processes: Patients completing the Sucampo 1131 trial that have shown good compliance will be offered the opportunity to participate in this trial. The electronic diary will continue to be used to record constipation medications and bowel habits. Lab be required at most visits.
Trial Details
Investigator:
Sunny Hussain, M.D.
IRB:
Quorum
IRB Number:
Trial Type:
Drug
Sponsor:
Sucampo
Contact Information:
(318) 212-8130
http://www.wkpgis.com